| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6248358 | AUXILIUM PHARMS LLC | Bioadhesive progressive hydration tablets and methods of making and using the same |
Aug, 2019
(4 years ago) | |
Striant is owned by Auxilium Pharms Llc.
Striant contains Testosterone.
Striant has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Striant are:
- US6248358
Striant was authorised for market use on 19 June, 2003.
Striant is available in tablet, extended release;buccal dosage forms.
Striant can be used as method of delivering an active ingredient using a progressive hydration bioadhesive.
The generics of Striant are possible to be released after 23 August, 2019.
Drugs and Companies using TESTOSTERONE ingredient
Market Authorisation Date: 19 June, 2003
Treatment: Method of delivering an active ingredient using a progressive hydration bioadhesive
Dosage: TABLET, EXTENDED RELEASE;BUCCAL
More Information on Dosage
STRIANT family patents
